| Literature DB >> 29249606 |
Jie Li1, Daniel Watterson2, Chiung-Wen Chang3, Xiao-Yan Che4, Xiao-Quan Li4, Daniel J Ericsson5, Li-Wen Qiu4, Jian-Piao Cai4, Jing Chen4, Scott R Fry6, Stacey T M Cheung3, Matthew A Cooper7, Paul R Young8, Bostjan Kobe9.
Abstract
Understanding the molecular basis of the neutralizing antibody response to dengue virus (DENV) is an essential component in the design and development of effective vaccines and immunotherapeutics. Here we present the structure of a cross-reactive, neutralizing antibody, 3E31, in complex with domain III (DIII) of the DENV envelope (E) protein and reveal a conserved, temperature-sensitive, cryptic epitope on DIII that is not available in any of the known conformations of E on the dengue virion. We observed that 3E31 inhibits E-mediated membrane fusion, suggesting that the antibody is able to neutralize virus through binding an as-yet uncharacterized intermediate conformation of DENV E and sterically block trimer formation. Finally, we show that, unlike cross-reactive fusion peptide-specific antibodies, 3E31 does not promote antibody-dependent enhancement of infection at sub-neutralizing concentrations. Our results highlight the 3E31 epitope on the E protein DIII as a promising target for immunotherapeutics or vaccine design.Entities:
Keywords: antibody-dependent enhancement; cross-reactive; cryptic epitope; dengue; membrane fusion; neutralizing antibody; temperature sensitive
Mesh:
Substances:
Year: 2017 PMID: 29249606 DOI: 10.1016/j.str.2017.11.017
Source DB: PubMed Journal: Structure ISSN: 0969-2126 Impact factor: 5.006